Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment

BACKGROUND: Since 2004, the US Food and Drug Administration’s (USFDA) dedicated drug review process in support of President’s Emergency Plan for AIDS Relief (PEPFAR) has made safe, effective and quality antiretrovirals (ARVs) available for millions of patients. Furthermore, the WHO and Global Fund t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chahal, Harinder Singh, Capella, Peter, Presto, Ryan, Murray, Jeffrey S, Shimer, Martin, Valdez, Mary Lou, Lurie, Peter G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969730/
https://www.ncbi.nlm.nih.gov/pubmed/29862054
http://dx.doi.org/10.1136/bmjgh-2017-000651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969730/
https://www.ncbi.nlm.nih.gov/pubmed/29862054
http://dx.doi.org/10.1136/bmjgh-2017-000651

Ejemplares similares